Joseph Wagner
Keine laufenden Positionen mehr
Vermögen: - $ am 30.04.2024
Profil
Dr. Joseph P.
Wagner is a Chief Scientific Officer at Notable Labs Ltd.
Dr. Wagner was previously employed as a President, Chief Executive Officer & Director by BriaCell Therapeutics Corp., a President by Cell Targeting, Inc., a Vice President-Cellular Therapy by Neuronyx, Inc., and a Chief Executive Officer by OncoCyte Corp.
He received his undergraduate degree from Rochester Christian University and a doctorate degree from Duke University School of Medicine.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
-.--% | 08.05.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Joseph Wagner
Unternehmen | Position | Beginn |
---|
Ehemalige bekannte Positionen von Joseph Wagner
Unternehmen | Position | Ende |
---|---|---|
BRIACELL THERAPEUTICS CORP. | Vorstandsvorsitzender | 24.03.2016 |
Neuronyx, Inc.
Neuronyx, Inc. Medical SpecialtiesHealth Technology Neuronyx, Inc. develops and distributes bone marrow derived stem cells. It also develops cellular therapies focusing on ischemic diseases to repair damaged cardiac tissues in patients suffering from heart attack. The company was founded by Hubert J.P. Schoemaker in 1999 and is located in Malvern, PA. | Corporate Officer/Principal | 13.10.2009 |
Cell Targeting, Inc.
Cell Targeting, Inc. BiotechnologyHealth Technology Part of Lineage Cell Therapeutics, Inc., Cell Targeting, Inc. is a company that provides research and development of aqueous-based synthetic solutions. The company is based in Cleveland, OH. Cell Targeting was acquired by Lineage Cell Therapeutics, Inc. on January 28, 2011 for $2.38 million. | Präsident | - |
ONCOCYTE CORPORATION | Vorstandsvorsitzender | - |
Ausbildung von Joseph Wagner
Duke University School of Medicine | Doctorate Degree |
Rochester Christian University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ONCOCYTE CORPORATION | Health Technology |
BRIACELL THERAPEUTICS CORP. | Health Technology |
Private Unternehmen | 2 |
---|---|
Neuronyx, Inc.
Neuronyx, Inc. Medical SpecialtiesHealth Technology Neuronyx, Inc. develops and distributes bone marrow derived stem cells. It also develops cellular therapies focusing on ischemic diseases to repair damaged cardiac tissues in patients suffering from heart attack. The company was founded by Hubert J.P. Schoemaker in 1999 and is located in Malvern, PA. | Health Technology |
Cell Targeting, Inc.
Cell Targeting, Inc. BiotechnologyHealth Technology Part of Lineage Cell Therapeutics, Inc., Cell Targeting, Inc. is a company that provides research and development of aqueous-based synthetic solutions. The company is based in Cleveland, OH. Cell Targeting was acquired by Lineage Cell Therapeutics, Inc. on January 28, 2011 for $2.38 million. | Health Technology |